Black History Month serves as a reminder to actively amplify Black voices, share stories and raise awareness throughout the ...
The U.S. Food and Drug Administration (FDA) issued a complete response letter requesting additional information from ...
A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in ...
Congress has taken the final steps in the FY 2026 budget process, passing legislation that increases funding for lupus programs, including $27 million - the most in history - for lupus programs at the ...
The U.S. Food and Drug Administration (FDA) has granted Biogen’s investigational drug, litifilimab, Breakthrough Therapy Designation for the treatment of cutaneous lupus erythematosus (CLE).
Interested in getting research like this straight to your inbox? Subscribe to our monthly Inside Lupus Research email for all the latest. Discover and match to lupus clinical trials faster with our ...
The U.S. Food and Drug Administration (FDA) approved Gazyva® to treat adults with lupus nephritis in October 2025. Gazyva targets and removes harmful B cells to help protect the kidneys in people with ...
Lupus affects different people in different ways. Many people with lupus have problems with the heart, lungs, and blood. How does lupus affect the heart, lungs, and blood? Your heart, blood vessels, ...
This video shows what it means to eat healthy when you have lupus and offers advice on how to make healthy choices in your daily diet. Healthy eating can make a big difference in your lupus symptoms ...
Our approach is innovative and removes barriers to progress. Watch this short video about three of our bold research initiatives to better understand lupus in children and teens, improve early ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results